Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/ADMA Biologics stock drops 24% after withdrawing financial guidance; law firm investigates potential securities violations.
ADMA
$8.62
-$0.25 -2.87%

ADMA Biologics stock drops 24% after withdrawing financial guidance; law firm investigates potential securities violations.

Market News
07 May 2026
Newsfile Corp
View Source
Bearish
pluang ai news

ADMA Biologics' stock fell over 24% after the company withdrew its long-term financial guidance, citing changes in the U.S. plasma and immunoglobulin markets. This followed allegations from Culper Research accusing ADMA of inflating growth through misleading practices. Law firm Block & Leviton is investigating potential securities law violations and may pursue legal action to help investors recover losses. Investors who suffered losses are encouraged to contact the firm for more information and possible legal support.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App